How to Prevent API Sorption in Plastic Packaging Systems


Published on 02/05/2026

Addressing API Sorption Risks in Plastic Packaging Systems

In a recent quality incident at a mid-sized pharmaceutical manufacturer, significant sorption of active pharmaceutical ingredients (APIs) was detected in a batch stored in plastic packaging systems. This case study examines the steps taken from detection to resolution, focusing on the importance of understanding packaging compatibility. By the end of this article, you will have a structured approach to manage API sorption issues and be better prepared for regulatory inspections.

This case study outlines practical actions—from identifying symptoms in the lab to implementing corrective and preventive action (CAPA) strategies—while providing evidence-based practices to ensure compliance with FDA, EMA, and ICH guidelines.

Symptoms/Signals on the Floor or in the Lab

The initial signs of API sorption were detected during routine stability testing, where a marked decrease in API concentration was observed. The predetermined specifications for product release were not met, leading to an investigation. Key symptoms included:

  • Decreased API concentration in stability samples.
  • Inconsistent results between different batches.
  • Unexpected variations in potency analysis.
  • Consumer complaints highlighting changes in formulation performance.

The laboratory staff noticed that the affected batches had

been stored in specific plastic containers. Cross-referencing these batches led to the identification of a suspect packaging material contributing to the sorption issue.

Likely Causes

Understanding the potential causes of API sorption is crucial for effective investigation. The causes can be categorized into six areas: Materials, Method, Machine, Man, Measurement, and Environment.

Category Cause Detail
Materials Packaging Compatibility Poor choice of plastic materials that do not interact well with APIs.
Method Improper Testing Protocols Inappropriate analytical methods leading to inaccurate conclusions.
Machine Storage Conditions Variations in temperature and humidity affecting API stability.
Man Lack of Training Staff unaware of the implications of packaging material selection.
Measurement Calibration Issues Faulty or uncalibrated instruments leading to data discrepancies.
Environment External Contaminants The impact of environmental factors, such as exposure to light.

This structured breakdown aids in pinpointing specific issues for deeper investigation.

Immediate Containment Actions (first 60 minutes)

Once the symptoms were identified, rapid containment actions were prioritized:

  • Quarantine all affected batches immediately to prevent further distribution.
  • Notify relevant authorities and stakeholders about the incident.
  • Initiate a review of all batch records and packaging material suppliers associated with the affected batches.
  • Perform an immediate risk assessment to evaluate potential impacts on patient safety and compliance.
  • Establish a multidisciplinary team to assess the situation.
Pharma Tip:  Primary Packaging for Controlled Substances: Security and Traceability Risks

Documentation of these steps is crucial for regulatory compliance and future investigations, ensuring that all actions are traceable.

Investigation Workflow (data to collect + how to interpret)

Cohesive investigation requires gathering and analyzing comprehensive data from multiple sources:

  • Stability Data: Review stability testing results over time to evaluate trends in API concentrations.
  • Batch Records: Examine documentation for discrepancies in packaging lot numbers and material specifications.
  • Supplier Information: Engage with suppliers to inquire about manufacturing changes or material inconsistencies.
  • Analytical Methods: Confirm the appropriateness and accuracy of the testing methodologies used during stability analysis.

The interpretation of this data should focus on identifying correlations between specific packaging materials and observed sorption incidents. Understanding these relationships is fundamental to a successful CAPA strategy.

Root Cause Tools (5-Why, Fishbone, Fault Tree) and When to Use Which

Selecting an appropriate root cause analysis (RCA) tool is essential for effective problem-solving:

  • 5-Why Analysis: This technique is useful for addressing straightforward problems where the causative pathway can be tracked through multiple ‘why’ questions. For instance, “Why was there decreased API concentration?” could unravel deeper issues related to packaging materials.
  • Fishbone Diagram: This tool provides a visual representation of potential causes related to the main problem. It is particularly effective for multifactor issues like API sorption, encompassing materials, methods, and machinery.
  • Fault Tree Analysis: A systematic, deductive analysis best suited for complex issues that require a detailed understanding of how different elements of the system interact and contribute to failures.

By applying the appropriate root cause analysis tool, the investigation team can ensure a comprehensive assessment of the sorption issue.

CAPA Strategy (correction, corrective action, preventive action)

Developing a robust CAPA strategy is key to addressing the identified issues:

  • Correction: Immediate correction involves identifying and quarantining the affected products and conducting additional stability testing.
  • Corrective Action: Implement targeted training for personnel on packaging material selection and improve the approval process for new suppliers. This may involve updating supplier qualification procedures to include specific tests for packaging compatibility.
  • Preventive Action: Establish ongoing monitoring of packaging materials used across the product line with regular reviews to detect any compatibility issues proactively. Additionally, conduct regular re-evaluations of current suppliers to ensure compliance with industry standards.
Pharma Tip:  Aluminum Tubes vs Laminated Tubes for Semi-Solid Products

A CAPA strategy must be not only actionable but also documented thoroughly to demonstrate compliance during inspections.

Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

A proactive control strategy ensures ongoing compliance and minimizes the risk of future issues:

Related Reads

  • Statistical Process Control (SPC): Use SPC to monitor deviations in API concentration over time to track the effectiveness of changes in packaging systems.
  • Sampling Plans: Establish defined sampling procedures for packaging components to examine their compatibility and sorption tendencies consistently.
  • Alarms and Alerts: Implement real-time monitoring systems for environmental controls, such as humidity and temperature variations, that may impact packaging integrity.
  • Verification: Regularly verify compliance through internal audits that assess the effectiveness of the control strategy, especially focusing on packaging materials.

Maintaining a forward-looking approach within the control strategy is essential for safeguarding the quality and integrity of pharmaceutical products.

Validation / Re-qualification / Change Control Impact (when needed)

When changes are made to packaging materials or processes, a thorough validation or re-qualification process is required:

  • Evaluate re-qualification needs whenever a new plastic material is selected. This includes compatibility testing with all affected APIs.
  • Document results and ensure full alignment with established validation guidelines as stipulated by the FDA, EMA, and ICH.
  • Establish a robust change control process to manage any modifications within the packaging system, including documentation of approvals and evaluations.

Validation activities must be meticulously documented to provide evidence of compliance and investigation due diligence.

Inspection Readiness: What Evidence to Show

Being prepared for regulatory inspections is vital. Inspectors look for the following evidence:

  • Records: Ensure that all batch records reflect accurate and consistent data pertaining to the issues identified.
  • Logs: Maintain detailed logs of investigations, CAPAs undertaken, and follow-up actions.
  • Batch Documentation: Provide complete records from the stability data, including any deviations observed during testing.
  • Deviation Reports: Present findings from the incident, showing a comprehensive RCA and the steps taken to mitigate risks and prevent recurrence.
  • Supplier Communication: Document communications with suppliers regarding material performance and any CAPA actions taken.
Pharma Tip:  Primary Packaging Selection for Biologics: Adsorption, Aggregation, and Silicone Risk

Being ready to present thorough, well-organized documentation reflects a commitment to compliance and quality assurance during inspections.

FAQs

What is API sorption?

API sorption occurs when active pharmaceutical ingredients adhere to the surfaces of packaging materials, leading to a decrease in the concentration of the API that reaches the intended dosage form.

How can API sorption be detected?

Detection typically involves stability testing of products over time, where significant changes in API concentration or potency may indicate sorption issues.

What role does packaging material play in API stability?

Packaging materials can interact with APIs, affecting their stability and efficacy—therefore, the choice of materials must be based on compatibility studies.

What immediate actions should be taken after detecting API sorption?

Immediate actions include quarantining affected batches, notifying relevant parties, and initiating an investigation into the packaging materials used.

What methodologies are best for root cause analysis?

Common methodologies include 5-Why analysis for simple issues, Fishbone diagrams for multifactor problems, and Fault Tree analysis for complex interactions.

How important is CAPA in addressing packaging issues?

Corrective and Preventive Action (CAPA) is critical to resolving immediate problems and preventing future occurrences, ensuring product integrity and compliance.

What is a control strategy in the context of packaging?

A control strategy involves ongoing monitoring of packaging materials and conditions throughout the lifecycle of the product to detect and mitigate risks proactively.

How often should packaging materials be re-evaluated?

Packaging materials should be re-evaluated regularly, especially if changes are made to suppliers or if any issues are detected in product stability.

What documentation is essential for inspection readiness?

Crucial documentation includes batch records, logs of investigations, deviation reports, supplier communications, and CAPA documentation.

What are the regulatory expectations for packaging materials?

Regulatory bodies expect that all packaging materials used in pharmaceutical products are assessed for compatibility, stability, and safety to ensure product quality.